Quanterix Corporation Current Income Tax Expense (Benefit)
Quanterix Corporation (QTRX) reported Current Income Tax Expense (Benefit) of $509.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-03-02
- Quanterix Corporation current income tax expense (benefit) for fiscal 2025 was $509.00K, a 29.31% decline from fiscal 2024.
- Quanterix Corporation current income tax expense (benefit) for fiscal 2024 was $720.00K, a 28.78% decline from fiscal 2023.
- Quanterix Corporation current income tax expense (benefit) for fiscal 2023 was $1.01M, a 120.26% increase from fiscal 2022.
- Quanterix Corporation current income tax expense (benefit) for fiscal 2022 was $459.00K, a 23.06% increase from fiscal 2021.
| Period end | Current Income Tax Expense (Benefit) 12 month | Current Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $509.00K 10-K · filed 2026-03-02 | |
| 2024-12-31 | $720.00K 10-K · filed 2026-03-02 | |
| 2023-12-31 | $1.01M 10-K · filed 2026-03-02 | |
| 2022-12-31 | $459.00K 10-K · filed 2025-03-17 | $445.00K 10-K · filed 2023-03-06 |
| 2021-12-31 | $373.00K 10-K/A · filed 2024-12-26 | $372.00K 10-K · filed 2022-03-01 |
| 2020-12-31 | $115.00K 10-K · filed 2023-03-06 | |
| 2019-12-31 | $113.00K 10-K · filed 2022-03-01 | |
| 2018-12-31 | $18.00K 10-K · filed 2021-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |